NATALIE PONTZER

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 348/H.R. 1763: The Resident Physician Shortage Reduction Act of 2019 S. 560/H.R. 1379: the Ensuring Lasting Smiles Act S. 966/ H.R. 2282: Medicare Care Coordination Improvement Act H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019 Valuation of Long-term Electroencephalogram monitoring; Issues associated with Qualified Clinical Data Registry implementation, measure licensing, approval, removal, benchmarking, and revision; Eliminating or streamlining requirements for prior authorization or step therapy; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.

S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.

S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.

S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 348/H.R. 1763: The Resident Physician Shortage Reduction Act of 2019 S. 560/H.R. 1379: the Ensuring Lasting Smiles Act S. 966/ H.R. 2282: Medicare Care Coordination Improvement Act H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019 Valuation of Long-term Electroencephalogram monitoring; Issues associated with Qualified Clinical Data Registry implementation, measure licensing, approval, removal, benchmarking, and revision; Eliminating or streamlining requirements for prior authorization or step therapy; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S.1622, Stopping Overdoses of Fentanyl Analogues Act; all provisions. S.2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2471: Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population Act of 2019; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. HR 3502, Protecting People from Surprise Medical Bills Act; all provisions. Authorizing and funding the pediatric loan repayment program. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act; all provisions. H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019; all provisions. H.R. 2282: Medicare Care Coordination Improvement Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. CMS proposed rule altering Evaluation and Management billing codes. Issues associated with defining a rehabilitation physician within the inpatient rehabilitation setting. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Appropriate use criteria for imaging services. Medicare coverage of oxygen therapy for cluster headaches.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 348/H.R. 1763: The Resident Physician Shortage Reduction Act of 2019 S. 560/H.R. 1379: the Ensuring Lasting Smiles Act S. 966/ H.R. 2282: Medicare Care Coordination Improvement Act H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019 Valuation of Long-term Electroencephalogram monitoring; Issues associated with Qualified Clinical Data Registry implementation, measure licensing, approval, removal, benchmarking, and revision; Eliminating or streamlining requirements for prior authorization or step therapy; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act; all provisions. H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019; all provisions. H.R. 2282: Medicare Care Coordination Improvement Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. CMS proposed rule altering Evaluation and Management billing codes. Issues associated with defining a rehabilitation physician within the inpatient rehabilitation setting. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Appropriate use criteria for imaging services. Medicare coverage of oxygen therapy for cluster headaches.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S.1622, Stopping Overdoses of Fentanyl Analogues Act; all provisions. S.2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2471: Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population Act of 2019; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. HR 3502, Protecting People from Surprise Medical Bills Act; all provisions. Authorizing and funding the pediatric loan repayment program. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S.1622, Stopping Overdoses of Fentanyl Analogues Act; all provisions. S.2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2471: Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population Act of 2019; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. HR 3502, Protecting People from Surprise Medical Bills Act; all provisions. Authorizing and funding the pediatric loan repayment program. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act; all provisions. H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019; all provisions. H.R. 2282: Medicare Care Coordination Improvement Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. CMS proposed rule altering Evaluation and Management billing codes. Issues associated with defining a rehabilitation physician within the inpatient rehabilitation setting. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Appropriate use criteria for imaging services. Medicare coverage of oxygen therapy for cluster headaches.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 348/H.R. 1763: The Resident Physician Shortage Reduction Act of 2019 S. 560/H.R. 1379: the Ensuring Lasting Smiles Act S. 966/ H.R. 2282: Medicare Care Coordination Improvement Act H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019 Valuation of Long-term Electroencephalogram monitoring; Issues associated with Qualified Clinical Data Registry implementation, measure licensing, approval, removal, benchmarking, and revision; Eliminating or streamlining requirements for prior authorization or step therapy; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act; all provisions. H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019; all provisions. H.R. 2282: Medicare Care Coordination Improvement Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. CMS proposed rule altering Evaluation and Management billing codes. Issues associated with defining a rehabilitation physician within the inpatient rehabilitation setting. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Appropriate use criteria for imaging services. Medicare coverage of oxygen therapy for cluster headaches.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 2543: Prescription Drug Pricing Reduction Act; sections 102, 107, 110, 121, 128, 141. HR 3: Lower Drug Costs Now Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Excluding non-invasive ventilators from the 2021 competitive bidding program CMS proposed rule altering Evaluation and Management and long-term electroencephalogram (EEG) billing codes. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Medicare coverage of oxygen therapy for cluster headaches.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S.1622, Stopping Overdoses of Fentanyl Analogues Act; all provisions. S.2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2471: Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population Act of 2019; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. HR 3502, Protecting People from Surprise Medical Bills Act; all provisions. Authorizing and funding the pediatric loan repayment program. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act; all provisions. H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019; all provisions. H.R. 2282: Medicare Care Coordination Improvement Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. CMS proposed rule altering Evaluation and Management billing codes. Issues associated with defining a rehabilitation physician within the inpatient rehabilitation setting. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Appropriate use criteria for imaging services. Medicare coverage of oxygen therapy for cluster headaches.

S. 2543: Prescription Drug Pricing Reduction Act; sections 102, 107, 110, 121, 128, 141. HR 3: Lower Drug Costs Now Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Excluding non-invasive ventilators from the 2021 competitive bidding program CMS proposed rule altering Evaluation and Management and long-term electroencephalogram (EEG) billing codes. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Medicare coverage of oxygen therapy for cluster headaches.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act; all provisions. H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019; all provisions. H.R. 2282: Medicare Care Coordination Improvement Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. CMS proposed rule altering Evaluation and Management billing codes. Issues associated with defining a rehabilitation physician within the inpatient rehabilitation setting. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Appropriate use criteria for imaging services. Medicare coverage of oxygen therapy for cluster headaches.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S.1622, Stopping Overdoses of Fentanyl Analogues Act; all provisions. S.2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2471: Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population Act of 2019; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. HR 3502, Protecting People from Surprise Medical Bills Act; all provisions. Authorizing and funding the pediatric loan repayment program. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S.1622, Stopping Overdoses of Fentanyl Analogues Act; all provisions. S.2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2471: Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population Act of 2019; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. HR 3502, Protecting People from Surprise Medical Bills Act; all provisions. Authorizing and funding the pediatric loan repayment program. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.

S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S.1622, Stopping Overdoses of Fentanyl Analogues Act; all provisions. S.2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2471: Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population Act of 2019; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. HR 3502, Protecting People from Surprise Medical Bills Act; all provisions. Authorizing and funding the pediatric loan repayment program. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S.1622, Stopping Overdoses of Fentanyl Analogues Act; all provisions. S.2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2471: Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population Act of 2019; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. HR 3502, Protecting People from Surprise Medical Bills Act; all provisions. Authorizing and funding the pediatric loan repayment program. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S.1622, Stopping Overdoses of Fentanyl Analogues Act; all provisions. S.2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2471: Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population Act of 2019; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. HR 3502, Protecting People from Surprise Medical Bills Act; all provisions. Authorizing and funding the pediatric loan repayment program. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 2543: Prescription Drug Pricing Reduction Act; sections 102, 107, 110, 121, 128, 141. HR 3: Lower Drug Costs Now Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Excluding non-invasive ventilators from the 2021 competitive bidding program CMS proposed rule altering Evaluation and Management and long-term electroencephalogram (EEG) billing codes. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Medicare coverage of oxygen therapy for cluster headaches.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S.1622, Stopping Overdoses of Fentanyl Analogues Act; all provisions. S.2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2471: Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population Act of 2019; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. HR 3502, Protecting People from Surprise Medical Bills Act; all provisions. Authorizing and funding the pediatric loan repayment program. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 348/H.R. 1763: The Resident Physician Shortage Reduction Act of 2019 S. 560/H.R. 1379: the Ensuring Lasting Smiles Act S. 966/ H.R. 2282: Medicare Care Coordination Improvement Act H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019 Valuation of Long-term Electroencephalogram monitoring; Issues associated with Qualified Clinical Data Registry implementation, measure licensing, approval, removal, benchmarking, and revision; Eliminating or streamlining requirements for prior authorization or step therapy; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 348/H.R. 1763: The Resident Physician Shortage Reduction Act of 2019 S. 560/H.R. 1379: the Ensuring Lasting Smiles Act S. 966/ H.R. 2282: Medicare Care Coordination Improvement Act H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019 Valuation of Long-term Electroencephalogram monitoring; Issues associated with Qualified Clinical Data Registry implementation, measure licensing, approval, removal, benchmarking, and revision; Eliminating or streamlining requirements for prior authorization or step therapy; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.

S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act; all provisions. H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019; all provisions. H.R. 2282: Medicare Care Coordination Improvement Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. CMS proposed rule altering Evaluation and Management billing codes. Issues associated with defining a rehabilitation physician within the inpatient rehabilitation setting. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Appropriate use criteria for imaging services. Medicare coverage of oxygen therapy for cluster headaches.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 348/H.R. 1763: The Resident Physician Shortage Reduction Act of 2019 S. 560/H.R. 1379: the Ensuring Lasting Smiles Act S. 966/ H.R. 2282: Medicare Care Coordination Improvement Act H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019 Valuation of Long-term Electroencephalogram monitoring; Issues associated with Qualified Clinical Data Registry implementation, measure licensing, approval, removal, benchmarking, and revision; Eliminating or streamlining requirements for prior authorization or step therapy; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act; all provisions. H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019; all provisions. H.R. 2282: Medicare Care Coordination Improvement Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. CMS proposed rule altering Evaluation and Management billing codes. Issues associated with defining a rehabilitation physician within the inpatient rehabilitation setting. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Appropriate use criteria for imaging services. Medicare coverage of oxygen therapy for cluster headaches.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S.1622, Stopping Overdoses of Fentanyl Analogues Act; all provisions. S.2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2471: Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population Act of 2019; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. HR 3502, Protecting People from Surprise Medical Bills Act; all provisions. Authorizing and funding the pediatric loan repayment program. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 348/H.R. 1763: The Resident Physician Shortage Reduction Act of 2019 S. 560/H.R. 1379: the Ensuring Lasting Smiles Act S. 966/ H.R. 2282: Medicare Care Coordination Improvement Act H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019 Valuation of Long-term Electroencephalogram monitoring; Issues associated with Qualified Clinical Data Registry implementation, measure licensing, approval, removal, benchmarking, and revision; Eliminating or streamlining requirements for prior authorization or step therapy; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.

S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.